Presentation
Related topics:
Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Global (non-specific), Medical Science Liaison
Availability: FREE
- What is the role of an MSL today in developing strategic relationships with KOLs.
- Learn what a typical ‘day in the life’ of an MSL is like.
- Is the role of an MSL here to stay for the long term?
Speaker
Sital Kotecha
Medical Strategy Director, Europe
Veeva Systems, UK
Presentation
Related topics:
Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Global (non-specific)
Availability: FREE
- The importance and benefits of an effective pre-market communication plan.
- The when, where and how of the various elements who need to be engaged.
- Development and implementation of the plan: Where the magic happens and results are driven!
- The essential elements to any pre-market communication plan.
- The need for achieving balance between the speed, timing and volume of pre-market communications.
Speaker
Tim Day
CEO & Principal
Innovative Strategic Communications, USA
Presentation
Related topics:
Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research, Global (non-specific)
Availability: FREE
- A review of success rates in recent drug launches.
- Look at where launches haven’t gone well and where RWE could have played a role in mitigating this: The bad.
- Building an Integrated Medical Plan to prepare for success (Begin with the end in mind): The good.
- The resource vs. demand challenge and the consequent benefit of outsourcing: The necessary.
Speaker
Alistair MacDonald
Executive Director, Real World Strategy
INC Research, UK
Presentation
Related topics:
Pharmaceutical/Biotech, Market Access & HEOR, Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research, Global (non-specific)
Availability: FREE
- Regulators and payer considerations of the ‘key value drivers’ in RWE generation.
- Highly successful RWE strategies, study designs and best practices and how they differ across global markets.
- How medical affairs can best utilise RWE to support market access decision making.
Speakers
Leanne Larson
Vice President and Global Head, Observational Research
Parexel, USA
Oliver Leatham
Vice President and Head, Pricing and Market Access
Parexel, UK
Presentation
Related topics:
Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Global (non-specific), Patient-Centricity & Care
Availability: FREE
- Apply a single framework for patient centricity in medical affairs.
- Uncover what patients value and how it changes on their treatment journey.
- Structure and prioritise innovative medical activities in a patientcentric way.
Speaker
Dominic Sloane
Development Director
Adelphi Communications, United Kingdom
Presentation
Related topics:
Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Global (non-specific), Digital & Technology
Availability: FREE
- Challenges facing medical affairs functions today.
- Medical affairs transformation as pipelines shift to specialty care.
- Getting to ‘world class’ through focus on delivering an exceptional stakeholder experience.
Speaker
Sital Kotecha
Medical Strategy Director, Europe
Veeva Systems, UK